John Neylan
Chief Tech/Sci/R&D Officer chez AKARI THERAPEUTICS, PLC
Fortune : - $ au 31/07/2023
Profil
John F.
Neylan is currently the Chief Medical Officer & Executive Vice President at Akari Therapeutics Plc.
Prior to this, he was the Chief Medical Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2015 to 2018.
He also held senior positions at Genzyme Corp.
and Wyeth Research.
Neylan was a Professor at Emory University and an Assistant Professor at the University of California, Davis.
He served as the President of The American Society of Transplantation.
Neylan received his undergraduate degree from Duke University and his doctorate from Rush Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKARI THERAPEUTICS PLC
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/07/2023 |
Postes actifs de John Neylan
| Sociétés | Poste | Début |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Chief Tech/Sci/R&D Officer | 08/11/2022 |
Anciens postes connus de John Neylan
| Sociétés | Poste | Fin |
|---|---|---|
| ANGN BIOM | Chief Tech/Sci/R&D Officer | 15/08/2022 |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 12/12/2018 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Corporate Officer/Principal | 01/05/2008 |
Advances In Kidney Disease & Health
 Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | Director/Board Member | - |
The American Society of Transplantation
 The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services The American Society of Transplantation (AST) is a non-profit organization founded in 1982 that aims to advance the field of transplantation and improve patient care through research, education, advocacy, organ donation, and community service. The non-profit company is based in Mount Laurel, NJ. With over 4,000 professional members, AST is the largest transplant organization in the United States and is recognized as the premier society for transplantation. The society is sought out by other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public for guidance, research, and resources related to transplantation. | President | - |
Formation de John Neylan
| Duke University | Undergraduate Degree |
| Rush Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKARI THERAPEUTICS, PLC | Health Technology |
| Entreprise privées | 6 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | Commercial Services |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Commercial Services |
The American Society of Transplantation
The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services The American Society of Transplantation (AST) is a non-profit organization founded in 1982 that aims to advance the field of transplantation and improve patient care through research, education, advocacy, organ donation, and community service. The non-profit company is based in Mount Laurel, NJ. With over 4,000 professional members, AST is the largest transplant organization in the United States and is recognized as the premier society for transplantation. The society is sought out by other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public for guidance, research, and resources related to transplantation. | Commercial Services |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
